Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site

State-of-the-art facility will headquarter research efforts in Boston and New York to accelerate the development of RNA and DNA-based medicines INDIANAPOLIS , Feb. 22, 2022 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) today announced the launch of the Lilly Institute for Genetic Medicine and